Announcements
- 2023.08.01 Articles of Association
- 2023.07.07 EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA
- 2023.07.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
- 2023.06.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
- 2023.05.31 POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 31, 2023
- 2023.05.16 POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING, THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS AND THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS
- 2023.05.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
- 2023.04.25 PROXY FORM FOR THE 2022 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 31, 2023
- 2023.04.25 NOTICE OF 2022 ANNUAL GENERAL MEETING
- 2023.04.25 (1) 2022 REPORT OF THE BOARD OF DIRECTORS (2) 2022 REPORT OF THE BOARD OF SUPERVISORS (3) 2022 AUDITED FINANCIAL STATEMENTS (4) 2022 ANNUAL REPORT (5) 2022 FINANCIAL ACCOUNTS REPORT (6) 2023 FINANCIAL BUDGET (7) 2022 ANNUAL PROFITS DISTRIBUTION PLAN (8) RE-APPOINTMENT OF AUDITOR (9) REMUNERATION OF DIRECTORS (10) REMUNERATION OF SUPERVISORS (11) UNCOVERED DEFICIT OF THE COMPANY AMOUNTING TO ONE-THIRD OF THE TOTAL SHARE CAPITAL AND (12) NOTICE OF 2022 ANNUAL GENERAL MEETING
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
